Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 93.79 · gapped above the open, then crossed back over prior close. High/low 97.00 at 8:00 am ET, 93.73 at 3:30 pm ET.
Mirum Pharmaceuticals, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
329 institutional managers report a position in Mirum Pharmaceuticals, Inc. worth $8.4B between them, filed on form 13F for the quarter ending 2026-06-30. 42 of them hold 80% of it, the largest being Frazier Life Sciences Management, L.P. at 10.73%.
304 more managers in the register
42 managers hold 80% of the $8.4B institutional base. The other 287 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Frazier Life Sciences Management, L.P., Jupiter Topco LLC, Capital World Investors +9 more · 10.73% of MIRM, 14.55% of NAMS
via Frazier Life Sciences Management, L.P., Wellington Management Group LLP, Eventide Asset Management, LLC +6 more · 10.73% of MIRM, 11.86% of MBX
via Jupiter Topco LLC, Wellington Management Group LLP, William Blair Investment Management, LLC +11 more · 8.25% of MIRM, 8.06% of MDGL
via Frazier Life Sciences Management, L.P., Jupiter Topco LLC, Eventide Asset Management, LLC +2 more · 10.73% of MIRM, 8.98% of ACHV
via Jupiter Topco LLC, Wellington Management Group LLP, Capital World Investors +10 more · 8.25% of MIRM, 8.67% of ARGX
via Jupiter Topco LLC, Wellington Management Group LLP, William Blair Investment Management, LLC +9 more · 8.25% of MIRM, 7.13% of PTCT
Managers holding a meaningful stake in MIRM also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
MIRM (Mirum Pharmaceuticals, Inc.) has 14 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move, and a bundle sits past the rings until you open it. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: PFE −0.67%, in healthcare.